Detalles de la búsqueda
1.
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Am J Hematol
; 95(9): 1006-1014, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32390196
2.
Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.
Biol Blood Marrow Transplant
; 24(1): 150-155, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28864139
3.
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.
Biol Blood Marrow Transplant
; 24(10): 2072-2080, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29928989
4.
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.
Biol Blood Marrow Transplant
; 23(3): 529-532, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28013014
5.
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Biol Blood Marrow Transplant
; 22(10): 1801-1807, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27377900
6.
Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia.
Bone Marrow Transplant
; 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38879608
7.
New allergies after cord blood transplantation.
Cytotherapy
; 15(10): 1259-65, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23993300
8.
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.
Transplant Cell Ther
; 28(5): 277.e1-277.e6, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181561
9.
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.
Haematologica
; 101(5): e204-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26819055
10.
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.
Cytotherapy
; 13(1): 78-82, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20586668
11.
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
EJHaem
; 1(2): 576-580, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709085
12.
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma.
Bone Marrow Transplant
; 55(6): 1137-1146, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992845
13.
Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).
Biol Blood Marrow Transplant
; 15(10): 1288-95, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19747637
14.
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
Clin Hematol Int
; 1(4): 229-233, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595434
15.
GVHD like skin eruption post-autologous stem cell transplantation.
Bone Marrow Transplant
; 59(6): 900-903, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467749
16.
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience.
Front Oncol
; 9: 623, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355140
17.
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.
Bone Marrow Transplant
; 53(6): 701-707, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703965
18.
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.
Leuk Lymphoma
; 48(9): 1728-35, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17786708
19.
Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
Blood
; 113(24): 6263-4, 2009 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19520823
20.
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
Cancer Res
; 62(14): 4132-41, 2002 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12124352